Abstract
Planned Interim Analysis of a Phase 2 Study of Loncastuximab Tesirine Plus Ibrutinib in Patients with Advanced Diffuse Large B-Cell Lymphoma (LOTIS-3)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have